123 related articles for article (PubMed ID: 3948133)
41. The controversial 'second-look' laparotomy.
Bokhman YaV ; Vinokurov VL; Gulo EI
Acta Obstet Gynecol Scand Suppl; 1992; 155():79-83. PubMed ID: 1502895
[TBL] [Abstract][Full Text] [Related]
42. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
43. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
[TBL] [Abstract][Full Text] [Related]
44. [Comparison of preoperative and postoperative chemotherapy in the treatment of advanced ovarian cancer].
Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):647-52. PubMed ID: 2671201
[TBL] [Abstract][Full Text] [Related]
45. Another look at the second-assessment procedure for ovarian epithelial carcinoma.
Gallup DG; Talledo OE; Dudzinski MR; Brown KW
Am J Obstet Gynecol; 1987 Sep; 157(3):590-6. PubMed ID: 3631160
[TBL] [Abstract][Full Text] [Related]
46. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
[TBL] [Abstract][Full Text] [Related]
47. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].
Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174
[TBL] [Abstract][Full Text] [Related]
48. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
Ojeda B; Llanos M; Brunet J; Lacasta A; Alonso MC; Rueda A; Delgado E; Badía J; López López JJ
Med Clin (Barc); 1995 Feb; 104(5):165-9. PubMed ID: 7877374
[TBL] [Abstract][Full Text] [Related]
49. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
[TBL] [Abstract][Full Text] [Related]
50. Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin.
Yokoyama Y; Kaji H; Kondoh H; Takeuchi E; Yamasaki Y; Inui Y
Gynecol Obstet Invest; 2001; 52(3):210-4. PubMed ID: 11598367
[TBL] [Abstract][Full Text] [Related]
51. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
52. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
53. Multimodal approach (surgery, chemotherapy, and radiotherapy) in the treatment of advanced ovarian carcinoma.
Steiner M; Rubinov R; Borovik R; Cohen Y; Robinson E
Cancer; 1985 Jun; 55(12):2748-52. PubMed ID: 4039626
[TBL] [Abstract][Full Text] [Related]
54. Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Duvillard P; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):346-52. PubMed ID: 20375795
[TBL] [Abstract][Full Text] [Related]
55. A second thought on second look laparotomy.
Bar-Am A; Kovner F; Lessing JB; Inbar M; Chaitchik S; Azem F; Brenner SH; Peyser MR
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):386-90. PubMed ID: 8392272
[TBL] [Abstract][Full Text] [Related]
56. [Clinical study of second-look operation (SLO) for primary ovarian cancer].
Shimamoto T; Jimi S; Watanabe Y; Kurano A; Maeda K; Shigematsu T; Ushijima H
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2737-43. PubMed ID: 2074382
[TBL] [Abstract][Full Text] [Related]
57. [The indications for second-look laparotomy in ovarian cancer patients].
Gulo EI; Vinokurov VL; Bokhman IaV
Vopr Onkol; 1992; 38(5):616-23. PubMed ID: 1300762
[TBL] [Abstract][Full Text] [Related]
58. [Secondary cytoreductions in the treatment of ovarian cancers].
Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
[TBL] [Abstract][Full Text] [Related]
59. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
Ivanov S; Ivanov S; Khadzhiolov N
Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
